Ishita Drugs & Industries was formally created and deployed as a legal entity in Feb.'92 by Jagdish Agarwal. The company created and deployed a project to manufacture bulk drugs at Sanand, in the Ahmedabad district of Gujarat with an installed capacity of 408 tpa. Commercial production commenced in Jan.'95.

Recession in some international markets and intense dumping of the Chinese exporters of the bulk drugs originally planned in the product range, necessiated a review by the company of its production programme and product range. It decided to undertake production of fluoro-quinolones, the latest broad spectrum anti-bacterials.

The company created and deployed an in-house R&D laboratory which has successfully engineered a highly improved process technology for norfloxacin. The in-house process technology for norfloxacin was implemented in its plant in Oct.'95.